German Health Minister Karl Lauterbach caught in alleged lie about breast cancer research project
(MENAFN) According to a report by Die Welt on Sunday, German Health Minister Karl Lauterbach allegedly falsely claimed to have led a government-funded breast cancer research project in 1995 when he applied for a professorship at the University of Tubingen.
The study, as described by Lauterbach, reportedly never existed. Lauterbach, who was 32 years old at the time, had recently received a Doctor of Science degree from the Harvard School of Public Health and had applied for the professorship in Tubingen, stating that he was the head of a research project into breast cancer diagnostics and therapy at an oncology department in Aachen.
He had also reportedly claimed that the project had received two million Deutschmarks (around USD1.38 million at the time) from the German government, and that he would transfer a portion of the funding to the cash-strapped university if he were hired. However, both the government and the Aachen oncology center told Die Welt that the project, as described by Lauterbach, never existed. The paper did note that a similar cancer study did take place at Aachen, but Lauterbach was not listed as an author.
The study, as described by Lauterbach, reportedly never existed. Lauterbach, who was 32 years old at the time, had recently received a Doctor of Science degree from the Harvard School of Public Health and had applied for the professorship in Tubingen, stating that he was the head of a research project into breast cancer diagnostics and therapy at an oncology department in Aachen.
He had also reportedly claimed that the project had received two million Deutschmarks (around USD1.38 million at the time) from the German government, and that he would transfer a portion of the funding to the cash-strapped university if he were hired. However, both the government and the Aachen oncology center told Die Welt that the project, as described by Lauterbach, never existed. The paper did note that a similar cancer study did take place at Aachen, but Lauterbach was not listed as an author.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Poppy Seed Market Size, Share, In-Depth Insights, Opportunity And Forecast 2025-2033
- Daytrading Publishes New Study On The Dangers Of AI Tools Used By Traders
- Origin Summit Debuts In Seoul During KBW As Flagship Gathering On IP, AI, And The Next Era Of Blockchain-Enabled Real-World Assets
- Chicago Clearing Corporation And Taxtec Announce Strategic Partnership
- Bitmex And Tradingview Announce Trading Campaign, Offering 100,000 USDT In Rewards And More
- ROVR Releases Open Dataset To Power The Future Of Spatial AI, Robotics, And Autonomous Systems
Comments
No comment